Can coaching help heart failure patients and caregivers feel better?
NCT ID NCT05211882
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This pilot study tested a 6-month nurse coaching program called ENABLE for heart failure patients and their caregivers in Singapore. The program aims to educate, nurture, and advise patients and caregivers to improve quality of life. The study enrolled 125 participants to see if the program is feasible and acceptable, and to get an early look at whether it might help.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- ENABLE nurse coaching program
- What this could lead to
- If it works, this could provide a supportive program to help heart failure patients and their caregivers feel better and manage daily life.
- What could go wrong
- This is a small pilot study testing feasibility, not effectiveness. The program may not improve quality of life or be acceptable to all participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
125 people
The number who actually took part.
- Started
-
Feb 2022
- Finished
-
Sep 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
21 to 99 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Inclusion criteria for patients: 1. 21 years or older. 2. Able to communicate in English or Chinese. 3. Have a diagnosis of HF (stage C or D) by the American College of Cardiology guidelines and be of New York Heart Association (NYHA) stage 2, 3 or 4 functional statuses. 4. Have an expected prognosis of at least 6 months. 5. Be on disease directed HF management. 6. Have had a hospitalization event within 6 months prior to recruitment. * Inclusion criteria for caregivers: 1. 21 years or older. 2. Able to communicate in English or Chinese. 3. Is a direct family caregiver of the patient. Exclusion Criteria: * Exclusion criteria for patients: 1. Patients who are unable to give informed consent 2. Patients who are already known to a palliative care service. * Exclusion criteria for caregivers: 1. Caregivers who are unable to give informed consent. 2. Caregivers who are domestic helpers.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Heart failure are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Cancer Centre Singapore
Singapore, Singapore
-
National Heart Centre Singapore
Singapore, Singapore
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which SGLT2 inhibitor wins? trial pits empagliflozin against dapagliflozin
- Can daily mindful breathing ease heart failure symptoms?
- Can a smartphone app keep heart failure patients out of the hospital?
- Can better training get doctors to talk about what matters most to dying veterans?
- Can AI read heart ultrasounds as well as trained sonographers?
- Can modern heart failure drugs reverse damage in three months?